FindTrial
Sign In

solution injectable en seringue pré-remplie

DRUG3 trials

Sponsors

Centre Hospitalier Universitaire De Saint Etienne, F. Hoffmann-La Roche AG, Centre Hospitalier Universitaire D'Angers

Conditions

Lower limb trauma requiring immobilisationMetastatic breast canceracute venous thromboembolism eventand HER2 positive and HER2 low breast cancer (HER2+/HER2-low BC)hormone receptor positive breast cancer (HR+ BC)including triple negative breast cancer (TNBC)

Phase 1

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients with Metastatic Breast Cancer (MORPHEUS-panBC)
RecruitingCTIS2023-503629-20-00
F. Hoffmann-La Roche AGand HER2 positive and HER2 low breast cancer (HER2+/HER2-low BC), hormone receptor positive breast cancer (HR+ BC), including triple negative breast cancer (TNBC) +1
Start: 2018-06-27Target: 50Updated: 2025-08-14

Phase 3

Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE
RecruitingCTIS2022-500974-33-00
Centre Hospitalier Universitaire De Saint Etienneacute venous thromboembolism event
Start: 2023-08-12Target: 1400Updated: 2025-04-25
RIVACAST - RIVAroxaban versus low-molecular weight heparin in patients with lower limb trauma requiring brace or CASTing
RecruitingCTIS2023-509905-62-00
Centre Hospitalier Universitaire D'AngersLower limb trauma requiring immobilisation
Start: 2024-07-19Target: 1424Updated: 2025-10-06